B. G. CHRISTENSEN

Statistics

Publications

Citations

3.3K

H-Index

Active since

1960

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Theravance Biopharma (United States)

B. G. CHRISTENSEN is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, chemistry, and drug discovery.

Publications per year

1960–2008

Publications

A stereocontrolled synthesis of (+)-thienamycin

T. N. SALZMANN, Ronald W. Ratcliffe, B. G. CHRISTENSEN et al. · Journal of the American Chemical Society · 1980 · 388 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6

Phosphonomycin: Structure and Synthesis

B. G. CHRISTENSEN, W. J. Leanza, T. R. BEATTIE et al. · Science · 1969 · 179 citations

Pharmacy, Medicinal Chemistry, Drug Discovery +5

Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)

Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI et al. · The Journal of Antibiotics · 2004 · 164 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

N-Acetimidoyl- and N-formimidoylthienamycin derivatives: antipseudomonal .beta.-lactam antibiotics

W. J. Leanza, Kenneth J. Wildonger, Thomas W. Miller et al. · Journal of Medicinal Chemistry · 1979 · 163 citations

Medicine, Medicinal Chemistry, Pharmacology +9

A novel synthesis of the carbapen-2-em ring system

Ronald W. Ratcliffe, T. N. SALZMANN, B. G. CHRISTENSEN · Tetrahedron Letters · 1980 · 163 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

1–5 of 60